art-3a10.1186-2f2050-5736-3-s1-o28

Upload: fatih-falah-zainal

Post on 07-Jul-2018

219 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/19/2019 art-3A10.1186-2F2050-5736-3-S1-O28

    1/1

    O R A L P R E S E N T A T I O N Open Access

     Treatment of mesial temporal lobe epilepsy usingMRgFUS: laboratory feasibility studyStephen Monteith1*, John Snell2, Matt Eames2, David Newell1, Ryder Gwinn1

    From  Current and Future Applications of Focused Ultrasound 2014. 4th International SymposiumWashington, D.C, USA. 12-16 October 2014

    Background/introduction

    Temporal lobe epilepsy remains a significant cause of 

    disabling morbidity. Patients that are refractory to medi-

    cal treatment are often considered for invasive surgery to remove the epileptogenic focus originating from the

    structures of the medial temporal lobe. A range of surgi-

    cal options now exist with varying degrees of efficacy.

    The goal of any surgical intervention is to minimize dis-

    ruption of adjacent normal cortical tissue while remov-

    ing the offending structures. MRgFUS provides the

    opportunity to perform this task in an elegant fashion.

    We tested the feasibility of this approach in a cadaveric

    model.

    Methods

    Cadaveric skulls were filled with custom fitted thermo

    reactive gels and thermocouples placed along anatomicalareas of interest along the skull base to assess temperature

    rises during the sonication process using the InSightec

    ExAblate Neuro System (650 Khz). The volume of tem-

    poral lobe structures typically removed by standard surgi-

    cal excision was mapped on 3D volumetric MRI scans and

    overlaid onto the thermal gels to provide an appropriate

    target for ablation. Temperature maps in the treatment

     volume were created for various sonication parameters

    and temperature effects at key skull base structures were

    monitored with thermocouples.

    Results and conclusionsBy adjusting sonication parameters it was possible to

    create a lesion of therapeutic significance in the required

    temporal lobe treatment volume using thermoreactive

    gels in cadaveric skulls. Temperature rises seen at the

    periphery of the target volume did decrease compared

    to more medial structures. Treatment of temporal lobe

    epilepsy with MRgFUS appears feasible based on this

    laboratory model. Thoughtful planning using a discon-

    nection strategy or highly focused sonications on key 

    anatomical epileptogenic foci may be required due tothe large volume required to ablate an equivalent

     volume for an anatomic temporal lobectomy. Blocking

    of distant FUS beams may be required to circumvent

    temperature rises in the anterolateral temporal fossa.

    Acknowledgements (Funding)

    Focused Ultrasound Foundation, Swedish Neuroscience Institute.

    Authors’  details1Swedish Neuroscience Institute, Seattle, WA, United States.   2Focused

    Ultrasound Foundation, Charlottesville, VA, United States.

    Published: 30 June 2015

    doi:10.1186/2050-5736-3-S1-O28Cite this article as:  Monteith  et al .:   Treatment of mesial temporal lobeepilepsy using MRgFUS: laboratory feasibility study.   Journal of Therapeutic Ultrasound  2015  3 (Suppl 1):O28.

    Submit your next manuscript to BioMed Centraland take full advantage of:

    • Convenient online submission

    • Thorough peer review

    • No space constraints or color figure charges

    • Immediate publication on acceptance

    • Inclusion in PubMed, CAS, Scopus and Google Scholar

    • Research which is freely available for redistribution

    Submit your manuscript atwww.biomedcentral.com/submit1Swedish Neuroscience Institute, Seattle, WA, United States

    Full list of author information is available at the end of the article

    Monteith  et al .   Journal of Therapeutic Ultrasound  2015,  3(Suppl 1):O28

    http://www.jtultrasound.com/content/3/S1/O28

    © 2015 Monteith et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the CreativeCommons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, andreproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver(http://creativecommons.org/publicdomain/zero/1.0/ ) applies to the data made available in this article, unless otherwise stated.

    http://creativecommons.org/licenses/by/4.0http://creativecommons.org/publicdomain/zero/1.0/http://creativecommons.org/publicdomain/zero/1.0/http://creativecommons.org/licenses/by/4.0